Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms Galium 68 VMT 02, VMT 02, VMT-02 + [1] |
Target |
Mechanism MC1R antagonists(Melanocortin receptor 1 antagonists), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma, Cutaneous Malignant | Phase 1 | US | 05 Mar 2021 | |
Metastatic melanoma | Phase 1 | US | 05 Mar 2021 | |
Mucosal Melanoma | Phase 1 | US | 05 Mar 2021 | |
Uveal Melanoma | Phase 1 | US | 05 Mar 2021 |